KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Other Working Capital Changes: 2014-2024

Historic Other Working Capital Changes for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to -$45.1 million.

  • BeOne Medicines' Other Working Capital Changes fell 385.41% to -$100.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$111.9 million, marking a year-over-year increase of 34.76%. This contributed to the annual value of -$45.1 million for FY2024, which is 82.34% up from last year.
  • As of FY2024, BeOne Medicines' Other Working Capital Changes stood at -$45.1 million, which was up 82.34% from -$255.6 million recorded in FY2023.
  • BeOne Medicines' Other Working Capital Changes' 5-year high stood at $56.2 million during FY2020, with a 5-year trough of -$256.5 million in FY2021.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$151.8 million (2022), whereas its average is -$150.8 million.
  • In the last 5 years, BeOne Medicines' Other Working Capital Changes spiked by 300.90% in 2020 and then slumped by 556.29% in 2021.
  • BeOne Medicines' Other Working Capital Changes (Yearly) stood at $56.2 million in 2020, then tumbled by 556.29% to -$256.5 million in 2021, then spiked by 40.82% to -$151.8 million in 2022, then plummeted by 68.35% to -$255.6 million in 2023, then soared by 82.34% to -$45.1 million in 2024.